A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K

NCT01486017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability of ASP015K
Pharmacokinetics of ASP015K
Healthy Subjects

Interventions

DRUG: ASP015K

Sponsor

Astellas Pharma Inc